Qube Research & Technologies (QRT)
BLTE

Qube Research & Technologies (QRT)’s Belite Bio BLTE Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-525
Closed -$16.6K – 4352
2023
Q3 		$16.6K Buy
+525
New +$13.2K ﹤0.01% 3201
2023
Q2 		– Sell
-7,528
Closed -$219K – 2416
2023
Q1 		$219K Sell
7,528
-3,093
-29% -$94K ﹤0.01% 1898
2022
Q4 		$325K Buy
10,621
+179
+2% +$5.27K ﹤0.01% 1629
2022
Q3 		$353K Buy
10,442
+3,802
+57% +$131K ﹤0.01% 1579
2022
Q2 		$207K Buy
+6,640
New +$124K ﹤0.01% 1726

Other funds holding BLTE

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s BLTE Position: Q4 2023 in Review

Qube Research & Technologies (QRT) sold out of Belite Bio (BLTE) in Q4 2023, closing a stake of 525 shares — an estimated $16.6K sold.

Qube Research & Technologies (QRT) first reported a position in BLTE in Q2 2022 and held it in 5 quarters. The position peaked at $353K in Q3 2022. 17 funds tracked by Wall St. Rank hold BLTE as of Q4 2023.

  • Qube Research & Technologies (QRT) reported no remaining Belite Bio position as of Q4 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 525 Belite Bio shares in Q4 2023, an estimated $16.6K.
  • Qube Research & Technologies (QRT) first reported a position in Belite Bio in Q2 2022 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s Belite Bio position peaked at $353K in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Belite Bio as of Q4 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2023, filed 13 Feb 2024.